BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Expression Profiles of Breast Tumors from Singapore and Europe

Dataset: Expression Profiles of Breast Tumors from Singapore and Europe

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that...

Registered by ArrayExpress Uploader
View Dataset

To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. al., Genome Biology, 2013. While the majority of the tumor expression profiles included in this database derived from publicly accessible microarray repositories, a number of the samples had not been previously published. Here, we describe the origin of these samples and provide their associated clinical and pathological annotations with the hope that other investigators will be able to utilize these data in their own research. Breast tumor samples derived from the Institut Jules Bordet (IJB; Belgium), John Radcliffe Hospital (JRH; Oxford) and the National University Hospital (NUH, Singapore) were profiled on the Affymetrix U133A platform. The number of tumors profiled (n) and the corresponding dates of tumor diagnosis are as follows. IJB: n=41, 1994-2001; JRH: n=8, 1990-1993; and NUH: n=100, 2000-2002.

Species:
human

Samples:
139

Source:
E-GEOD-45255

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DMFS TIME HER2 STATUS PATIENT AGE PGR STATUS HISTOLOGICAL GRADE SIZE MM LN STATUS TREATMENT TYPE DFS TIME DSS TIME DMFS EVENT DEFINED AS DISTANT METASTASIS OR DEATH FROM BREAST CANCER CHARACTERISTICS YES DSS EVENT DEFINED AS DEATH FROM BREAST CANCER ER STATUS DFS EVENT DEFINED AS ANY TYPE OF RECURRENCE OR DEATH FROM BREAST CANCER HISTOLOGY
GSM1100175 9.419 NA 43 NA G1 21 LN- none 9.42 NA not specified endocrine? (0=no, 1=yes): 0 not specified NA ER+ not specified NA
GSM1100174 10.614 NA 37 NA G2 23 LN- none 10.61 NA not specified endocrine? (0=no, 1=yes): 0 not specified NA ER- 1 NA
GSM1100173 7.151 NA 67 NA NA 10 LN- none 7.15 NA 1 endocrine? (0=no, 1=yes): 0 not specified NA ER- 1 NA
GSM1100172 1.66 He- 50 PgR- G3 29 LN- CMFx6 NA 1.66027397260274 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- NA NA
GSM110017 4.51 He- 72 PgR- G2 20 LN- tamoxifen NA 4.50958904109589 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100170 3.93 He+ 56 PgR+ G1 30 LN- tamoxifen NA 3.92602739726027 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100169 4.96 He- 46 PgR- G3 27 LN- CMFx6; Tamoxifen NA 4.95890410958904 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- NA NA
GSM1100168 4.56 He+ 45 PgR+ G2 30 LN- tamoxifen NA 4.56164383561644 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100167 5.01 He+ 48 PgR- G3 60 LN- CMFx6 NA 5.00821917808219 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- NA NA
GSM1100166 4.64 He- 45 PgR+ G2 20 LN- CMFx6 NA 4.64383561643836 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ NA NA
GSM1100165 5.13 He- 70 PgR- G2 20 LN- tamoxifen NA 5.13424657534247 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100164 6.26 NA 59 PgR- G3 45 LN- ACx4 NA 6.25753424657534 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- NA NA
GSM1100163 5.57 He- 61 PgR- G3 14 LN- CMFx6; Arimidex/Tamoxifen NA 5.56712328767123 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- NA NA
GSM1100162 5.11 He- 60 PgR+ G3 20 LN- ACx4; Arimidex/Tamoxifen NA 5.10958904109589 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM110016 5.52 He- 53 PgR+ G3 19 LN- tamoxifen NA 5.52328767123288 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100160 6.69 He- 42 PgR+ G2 14 LN- CMFx6 NA 6.69315068493151 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ NA NA
GSM1100159 6.19 He- 73 PgR- NA 38 LN- NA NA 6.18630136986301 not specified endocrine? (0=no, 1=yes): NA NA not specified ER- NA NA
GSM1100158 2.57 NA 46 NA G3 32 LN- CMFx6; Tamoxifen NA 2.57260273972603 not specified endocrine? (0=no, 1=yes): 1 1 not specified NA NA NA
GSM1100157 3.12 He+ 57 PgR- G1 20 LN- tamoxifen NA 3.11506849315069 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100156 5.94 He- 66 PgR+ G1 27 LN- tamoxifen NA 5.93698630136986 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100155 6.13 He+ 62 PgR+ G3 27 LN- tamoxifen NA 6.12876712328767 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100154 6.61 He- 67 PgR- G3 40 LN- ACx6; Tamoxifen NA 6.61369863013699 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- NA NA
GSM1100153 6.65 He+ 70 PgR- G2 35 LN- tamoxifen NA 6.65205479452055 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100152 6.18 He+ 77 PgR+ G2 15 LN- tamoxifen NA 6.17534246575342 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM110015 6.02 He+ 52 PgR- G2 20 LN- ACx4; Tamoxifen NA 6.01917808219178 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- NA NA
GSM1100150 7.57 He+ 81 PgR- G2 20 LN- tamoxifen NA 7.57260273972603 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100149 7.31 He- 55 PgR+ G3 18 LN- tamoxifen NA 7.30684931506849 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100148 7.85 He+ 48 NA G2 12 LN- Tamoxifen+Zoledronic acid NA 7.85479452054795 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100147 7.82 He- 54 PgR- G2 10 LN- tamoxifen NA 7.82191780821918 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- NA NA
GSM1100146 3.30 He+ 72 PgR+ G3 37 LN- Arimidex/Tamoxifen NA 5.16438356164384 1 endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100145 3.65 He- 60 PgR+ G3 40 LN- CMFx2; Tamoxifen NA 6.75068493150685 1 endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM1100144 6.15 He- 54 PgR- G1 55 LN- ACx4 NA 8.02191780821918 1 endocrine? (0=no, 1=yes): 0 1 not specified ER+ NA NA
GSM1100143 2.42 He- 36 PgR- G2 13 LN- Tamoxifen+Zoledronic acid NA 7.07945205479452 1 endocrine? (0=no, 1=yes): 1 1 not specified ER- NA NA
GSM1100142 2.18 He- 46 PgR- G1 10 LN- Tamoxifen+Zoledronic acid NA 2.18904109589041 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ NA NA
GSM110014 0.76 He+ 70 PgR+ G3 35 LN- tamoxifen NA 0.991780821917808 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM1100140 3.80 He- 73 PgR- G3 34 LN- ACx3/CMFx1 NA 4.62191780821918 1 endocrine? (0=no, 1=yes): 0 1 1 ER- NA NA
GSM1100139 2.21 He- 63 PgR+ G3 46 LN- tamoxifen NA 4.92876712328767 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM1100138 1.35 He- 38 PgR- G3 32 LN- ECx4; Tamoxifen NA 2.75342465753425 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM1100137 0.25 He+ 57 PgR+ NA 85 LN- tamoxifen NA 5.03561643835616 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM1100136 4.51 He- 68 PgR+ G3 17 LN- tamoxifen NA 6.17260273972603 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM1100135 4.18 He- 66 PgR- G3 21 LN- tamoxifen NA 4.19452054794521 1 endocrine? (0=no, 1=yes): 1 1 1 ER- NA NA
GSM1100134 0.65 He+ 59 PgR- G3 25 LN- tamoxifen NA 3.07945205479452 1 endocrine? (0=no, 1=yes): 1 1 1 ER- NA NA
GSM1100133 1.39 He+ 47 PgR+ G3 28 LN- CMFx6; Tamoxifen NA 2.12602739726027 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM1100132 3.05 He+ 63 NA G2 30 LN- tamoxifen NA 3.44931506849315 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ NA NA
GSM110013 4.33 NA 53 PgR+ G3 35 LN+ Tam+CMFx6 cycles 4.33 4.33 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100130 4.83 He- 59 PgR+ G1 60 LN+ NA 4.83 4.83 not specified endocrine? (0=no, 1=yes): NA NA not specified ER+ not specified invasive ductal carcinoma
GSM1100129 4.38 He- 62 PgR+ G3 20 LN- tamoxifen 4.38 4.38 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100128 2.67 He- 43 PgR+ G1 24 LN+ Tam+ACx4 cycles 2.67 2.67 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100127 4.67 NA 55 NA G1 25 LN- none 4.67 4.67 not specified endocrine? (0=no, 1=yes): 0 not specified not specified NA not specified invasive ductal carcinoma and papillary carcinoma
GSM1100126 0.83 He- 84 PgR+ G3 28 LN- tamoxifen 0.83 0.83 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100125 2.00 He+ 38 PgR+ G3 40 LN+ Tam+AC 2.00 2.00 1 endocrine? (0=no, 1=yes): 1 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100124 4.92 He+ 67 PgR- G3 25 LN+ tamoxifen 4.92 4.92 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100123 5.17 He- 52 PgR+ G1 20 LN- tamoxifen 5.17 5.17 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive lobular carcinoma
GSM1100122 3.83 He+ 50 PgR+ G3 16 LN+ Tam+ACx4 cycles 3.83 5.75 1 endocrine? (0=no, 1=yes): 1 1 not specified ER- 1 invasive ductal carcinoma
GSM110012 5.21 He+ 64 PgR+ G3 50 LN- tamoxifen 5.21 5.21 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified medullary carcinoma
GSM1100120 4.54 He- 47 PgR+ G3 30 LN+ CAF 4.54 4.54 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100119 5.58 He+ 38 PgR+ G3 38 LN- Tam+ACx4 cycles 5.58 5.58 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100118 5.92 He+ 58 PgR+ G3 51 LN+ Tam+ACx4 cycles 5.92 5.92 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100117 5.88 He+ 47 PgR- G3 21 LN- ACx4 cycles 5.88 5.88 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100116 5.79 He- 51 PgR- G3 18 LN- Tam+CMFx6 cycles 5.79 5.79 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100115 5.83 He+ 48 PgR- G3 35 LN- ACx4 cycles 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100114 5.83 He- 46 PgR- G3 25 LN- ACx4 cycles 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100113 1.33 He+ 51 PgR- G3 27 LN- ACx4 cycles 1.92 5.58 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- 1 invasive ductal carcinoma
GSM1100112 6.17 He- 36 PgR+ G3 25 LN- Tam+CMFx6 cycles 6.17 6.17 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100 5.83 He+ 61 PgR- G3 15 LN+ CAFx6 cycles 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100110 5.71 He+ 48 PgR- G3 32 LN- ACx4 cycles 5.71 5.71 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100109 5.88 He- 61 PgR- G3 25 LN+ CMF 5.88 5.88 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100108 1.17 He- 42 PgR- G3 20 LN- none 1.17 6.50 not specified endocrine? (0=no, 1=yes): 0 not specified not specified ER- not specified medullary carcinoma
GSM1100107 3.50 He- 77 PgR+ G1 40 LN- tamoxifen 3.50 4.33 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100106 NA He- 81 PgR+ G1 40 LN- tamoxifen NA NA NA endocrine? (0=no, 1=yes): 1 1 NA ER+ NA papillary carcinoma
GSM1100105 4.00 He+ 42 PgR- G3 23 LN- NA 4.00 4.00 not specified endocrine? (0=no, 1=yes): NA NA not specified ER- not specified invasive ductal carcinoma
GSM1100104 2.29 He+ 38 PgR- G3 36 LN- Tam+ACx4 cycles 2.29 2.88 1 endocrine? (0=no, 1=yes): 1 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100103 0.79 He+ 51 PgR- G3 30 LN+ ACx4 cycles 0.79 1.46 1 endocrine? (0=no, 1=yes): 0 1 not specified ER- 1 invasive ductal carcinoma
GSM1100102 5.58 He- 60 PgR+ G1 15 LN- Tam+CMFx6 cycles 5.58 5.79 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM110010 6.29 He+ 52 PgR+ G3 45 LN+ Tam+ACx4 cycles 6.29 6.29 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100100 0.75 He- 48 PgR- G3 35 LN- ACx4 cycles 0.75 0.75 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100099 4.17 He- 42 PgR- G3 22 LN- AC 4.17 4.25 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100098 5.08 He- 48 PgR- G3 30 LN+ ACx4 cycles 5.08 5.08 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100097 4.38 He+ 34 PgR+ G3 35 LN+ ACx8 cycles; taxol 4.38 4.38 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100096 2.21 He- 29 PgR+ G1 80 LN+ CAFx6 cycles 2.21 3.04 1 endocrine? (0=no, 1=yes): 0 1 1 ER+ 1 invasive lobular carcinoma
GSM1100095 3.13 He- 86 PgR+ G1 21 LN+ tamoxifen 3.13 4.38 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100094 1.29 He+ 54 PgR- G3 35 LN+ CAF 1.29 1.38 1 endocrine? (0=no, 1=yes): 0 1 1 ER- 1 invasive ductal carcinoma
GSM1100093 0.13 He+ 46 PgR- G3 22 LN+ NA 0.13 0.38 1 endocrine? (0=no, 1=yes): NA NA 1 ER- 1 invasive ductal carcinoma
GSM1100092 5.54 He- 41 PgR- G3 40 LN- ACx4 cycles 5.54 5.54 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM110009 1.96 He- 80 PgR+ G3 40 LN+ tamoxifen 1.96 1.96 1 endocrine? (0=no, 1=yes): 1 1 not specified ER+ 1 invasive ductal carcinoma
GSM1100090 4.83 He+ 45 PgR- G3 20 LN+ CAF 4.83 4.83 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100089 5.08 He+ 64 PgR- G3 30 LN- ACx4 cycles 5.08 5.08 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100088 0.88 He+ 62 PgR- G3 35 LN+ none 0.88 1.00 1 endocrine? (0=no, 1=yes): 0 not specified not specified ER- 1 invasive ductal carcinoma
GSM1100087 0.00 He+ 62 PgR+ G3 25 LN+ Arimidex+CMFx2 cycles 0.00 2.08 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ 1 invasive ductal carcinoma
GSM1100086 1.96 He+ 58 PgR+ G3 30 LN+ CAF 1.96 1.96 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100085 5.25 He+ 45 PgR+ G3 25 LN+ AC 5.25 5.29 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100084 3.96 He+ 54 PgR- G3 20 LN+ ACx4 cycles 3.96 4.63 1 endocrine? (0=no, 1=yes): 0 1 1 ER- 1 invasive ductal carcinoma
GSM1100083 4.00 NA 44 PgR- G3 50 LN+ ACx4 cycles 4.00 4.00 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100082 2.04 He+ 74 PgR- G3 30 LN+ tamoxifen 2.04 2.25 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ 1 invasive ductal carcinoma
GSM110008 4.00 He+ 52 PgR- G3 35 LN+ ACx4 cycles 4.00 4.33 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive lobular carcinoma
GSM1100080 1.00 He+ 55 PgR- G3 60 LN- ACx4 cycles 1.00 5.00 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100079 0.13 He- 66 PgR+ G1 38 LN- tamoxifen NA 0.13 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified mucinous carcinoma
GSM1100078 4.88 He- 47 PgR+ G3 32 LN+ CAF 4.88 4.88 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100077 4.46 He+ 55 PgR+ G3 20 LN- tamoxifen 4.46 4.46 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100076 5.46 He- 45 PgR+ G1 15 LN- tamoxifen;goserelin 5.46 5.46 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100075 1.54 He+ 34 PgR- G3 40 LN- ACx4 cycles 1.54 5.46 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100074 5.00 He- 47 PgR+ G2 35 LN- ACx4 cycles 5.00 5.00 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100073 5.33 He- 49 PgR+ G2 15 LN- tamoxifen 5.33 5.33 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100072 5.58 He- 64 PgR+ G2 12 LN- tamoxifen 5.58 5.58 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM110007 NA He+ 66 PgR+ G2 17 LN- NA NA 0.08 NA endocrine? (0=no, 1=yes): NA NA not specified ER+ NA invasive ductal carcinoma
GSM1100070 4.00 He- 46 PgR+ G2 40 LN+ NA 4.00 4.50 not specified endocrine? (0=no, 1=yes): NA NA not specified ER- not specified invasive ductal and lobular carcinoma
GSM1100069 4.83 He- 73 PgR+ G2 20 LN+ tamoxifen 4.83 4.92 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100068 4.88 He- 46 PgR+ G2 15 LN- Tam+CMFx6 cycles 4.88 4.88 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100067 4.50 He- 42 PgR- G2 30 LN+ NA 4.50 4.50 not specified endocrine? (0=no, 1=yes): NA NA not specified ER+ not specified invasive ductal carcinoma
GSM1100066 1.67 He+ 46 PgR- G2 60 LN+ Tam+CAFx2 cycles 1.67 1.75 1 endocrine? (0=no, 1=yes): 1 1 1 ER+ 1 invasive ductal carcinoma
GSM1100065 0.42 He+ 44 PgR+ G2 24 LN+ none 0.42 0.42 not specified endocrine? (0=no, 1=yes): 0 not specified not specified ER+ not specified invasive ductal carcinoma
GSM1100064 4.92 He- 55 PgR+ G2 19 LN+ tamoxifen 4.92 4.92 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100063 4.75 He+ 57 PgR+ G2 21 LN- tamoxifen 4.75 4.75 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100062 5.17 He- 40 PgR+ G2 23 LN+ CAF 5.17 5.17 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM110006 4.67 He- 44 PgR+ G2 35 LN- CMF 4.67 4.67 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100060 5.67 He+ 46 PgR+ G2 30 LN+ CAF 5.67 5.67 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100059 4.67 He- 35 PgR+ G2 40 LN- Tam+ACx4 cycles 4.67 4.67 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- not specified invasive ductal carcinoma
GSM1100058 0.67 He- 55 PgR+ G2 15 LN- none 1.25 4.58 not specified endocrine? (0=no, 1=yes): 0 not specified not specified ER+ 1 invasive ductal carcinoma
GSM1100057 2.83 He+ 67 PgR- G2 25 LN- none 2.83 2.83 1 endocrine? (0=no, 1=yes): 0 not specified not specified ER- 1 invasive ductal carcinoma
GSM1100056 0.67 He+ 75 PgR+ G2 40 LN+ tamoxifen 0.92 5.42 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER- 1 invasive ductal carcinoma
GSM1100055 0.04 He- 48 PgR- G2 15 LN- anastrozole;taxol 0.04 3.08 1 endocrine? (0=no, 1=yes): 0 1 1 ER+ 1 invasive lobular carcinoma
GSM1100054 5.25 He+ 49 PgR+ G2 23 LN+ Tam+CAFx6 cycles 5.25 5.25 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100053 5.00 He- 69 PgR+ G2 25 LN+ CAF 5.00 5.00 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100052 NA He+ 51 PgR- G2 25 LN+ Tam+ACx8;taxol NA NA NA endocrine? (0=no, 1=yes): 1 1 NA ER+ NA invasive ductal carcinoma
GSM110005 6.33 He- 60 PgR+ G2 20 LN- Tam+CMFx6 cycles 6.33 6.33 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100050 5.58 He+ 77 PgR- G2 35 LN- tamoxifen 5.58 5.58 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100049 5.75 He- 53 PgR+ G2 22 LN+ CMF 5.75 5.92 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100048 5.83 He- 50 PgR+ G2 25 LN+ CAF 5.83 5.83 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER- not specified invasive ductal carcinoma
GSM1100047 5.79 He- 52 PgR+ G2 18 LN- CMF 5.79 5.79 not specified endocrine? (0=no, 1=yes): 0 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100046 6.00 He- 53 PgR- G2 18 LN- tamoxifen 6.00 6.00 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100045 4.04 He+ 46 PgR- G2 15 LN- none 4.04 4.08 not specified endocrine? (0=no, 1=yes): 0 not specified not specified ER- not specified invasive ductal carcinoma
GSM1100044 5.63 He+ 48 PgR+ G2 20 LN- NA 5.63 5.63 not specified endocrine? (0=no, 1=yes): NA NA not specified ER+ not specified invasive ductal carcinoma
GSM1100043 2.00 He+ 54 PgR- G2 60 LN+ ACx4 cycles 2.00 2.25 1 endocrine? (0=no, 1=yes): 0 1 not specified ER- 1 invasive ductal carcinoma
GSM1100042 6.25 He+ 69 PgR- G2 25 LN- tamoxifen 6.25 6.25 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM110004 2.63 He+ 40 PgR+ G2 25 LN- Tam+CMFx6 cycles 2.63 2.63 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100040 5.88 He- 69 PgR+ G2 35 LN- tamoxifen 5.88 6.04 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100039 4.29 He- 69 PgR+ G2 30 LN- tamoxifen 4.29 4.29 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma
GSM1100038 1.13 He+ 62 PgR- G2 30 LN+ ACx4 cycles 1.13 1.13 1 endocrine? (0=no, 1=yes): 0 1 not specified ER- 1 invasive ductal carcinoma
GSM1100037 6.17 He- 41 PgR+ G2 20 LN- Tam+ACx4 cycles 6.17 6.17 not specified endocrine? (0=no, 1=yes): 1 1 not specified ER+ not specified invasive ductal carcinoma

Tags

  • breast
  • breast cancer
  • cancer
  • genome

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use